Company Info
| Year Established: | 2011 |
Contacts
| Primary: | Stephen Brady CEO |
| Other: | Sam Whiting, M.D., Ph.D. CMO & Head of R&D Darrin Bomba VP, Development Operations Nicholas Maestas VP, Strategy & Finance |
Company Description
Tempest Therapeutics is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.
